Bharat Biotech
-
Health
India unveils world’s first intranasal Covid vaccine iNNCOVACC
New Delhi: Indian government on Thursday unveiled indigenously made, world’s first intranasal Covid-19 vaccine iNNCOVACC here. The vaccine was launched…
Read More » -
Covid19
Bharat Biotech’s intranasal Covid vaccine priced at Rs 800
Hyderabad: Vaccine maker Bharat Biotech’s intranasal vaccine for Covid-19, the first in the world, is scheduled to be introduced in the…
Read More » -
Health
Centre approves Bharat Biotech’s intranasal Covid vaccine for booster
New Delhi: The Centre on Friday approved Bharat Biotech’s needle-free intranasal Covid vaccine for booster dose, said an official source.…
Read More » -
Covid19
World’s 1st Intranasal Covid vax from Bharat Biotech gets CDSCO approval
Hyderabad: Leading vaccine maker, Bharat Biotech International Limited (BBIL) on Monday announced that world’s first intranasal vaccine for Covid-19, iNCOVACC (BBV154),…
Read More » -
Health
No external pressure to accelerate Covaxin development: Bharat Biotech
Hyderabad: Vaccine-maker Bharat Biotech has denied that there was any external pressure to accelerate development of Covaxin, its vaccine for…
Read More » -
Covid19
Bharat Biotech evinces interest to invest in K’taka
Bengaluru: Covaxin maker Dr. Krishna M. Ella has evinced interest in investing in Karnataka. Ella, Chairman and MD of Bharat Biotech,…
Read More » -
Health
Bharat Biotech’s intranasal Covid vaccine proven safe in clinical trials
Hyderabad: Vaccine-maker Bharat Biotech announced on Monday that its intranasal vaccine for Covid-19 has been proven to be safe, well-tolerated, and…
Read More » -
Nasal Covid-19 vaccine could soon become a reality in India
Hyderabad: Bharat Biotech has completed a clinical trial for the world’s first clinically proven nasal Covid-19 vaccine. Bharat Biotech International…
Read More » -
Covaxin Booster can Neutralise Omicron: Bharat Biotech
New Delhi: Covaxin’s booster dose is able to neutralise the vaccine evading Omicron variant of Covid-19, according to a study conducted…
Read More » -
Bharat Biotech Seeks Approval for Phase 3 Trials of Intranasal Vaccine
Hyderabad: Bharat Biotech has sought the approval of the Drug Controller General of India (DCGI) to conduct Phase 3 trials of…
Read More »